Literature DB >> 34479656

Are 5-Year Randomized Clinical Trial Results Sufficient for Implementation of Short-Course Whole Breast Radiation Therapy?

Erin F Gillespie1, Atif J Khan2, Oren Cahlon2, Lior Z Braunstein2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34479656      PMCID： PMC9227962          DOI： 10.1016/j.prro.2021.03.011

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN： 1879-8500


× No keyword cloud information.
  28 in total

1.  First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Authors:  Rajiv K Agrawal; Abdulla Alhasso; Peter J Barrett-Lee; Judith M Bliss; Peter Bliss; David Bloomfield; Joanna Bowen; A Murray Brunt; Ellen Donovan; Marie Emson; Andrew Goodman; Adrian Harnett; Joanne S Haviland; Ronald Kaggwa; James P Morden; Anne Robinson; Sandra Simmons; Alan Stewart; Mark A Sydenham; Isabel Syndikus; Jean Tremlett; Yat Tsang; Duncan Wheatley; Karen Venables; John R Yarnold
Journal:  Radiother Oncol       Date:  2011-07       Impact factor: 6.280

2.  External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.

Authors:  Timothy J Whelan; Jim A Julian; Tanya S Berrang; Do-Hoon Kim; Isabelle Germain; Alan M Nichol; Mohamed Akra; Sophie Lavertu; Francois Germain; Anthony Fyles; Theresa Trotter; Francisco E Perera; Susan Balkwill; Susan Chafe; Thomas McGowan; Thierry Muanza; Wayne A Beckham; Boon H Chua; Chu Shu Gu; Mark N Levine; Ivo A Olivotto
Journal:  Lancet       Date:  2019-12-05       Impact factor: 79.321

3.  Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.

Authors:  Lior Z Braunstein; Alphonse G Taghian; Andrzej Niemierko; Laura Salama; Alexander Capuco; Jennifer R Bellon; Julia S Wong; Rinaa S Punglia; Shannon M MacDonald; Jay R Harris
Journal:  Breast Cancer Res Treat       Date:  2016-11-03       Impact factor: 4.872

4.  Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.

Authors:  Ravi B Parikh; Ezra Fishman; Winnie Chi; Robert P Zimmerman; Atul Gupta; John J Barron; Gosia Sylwestrzak; Justin E Bekelman
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777

5.  Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.

Authors:  Adrian Murray Brunt; Joanne S Haviland; Mark Sydenham; Rajiv K Agrawal; Hafiz Algurafi; Abdulla Alhasso; Peter Barrett-Lee; Peter Bliss; David Bloomfield; Joanna Bowen; Ellen Donovan; Andy Goodman; Adrian Harnett; Martin Hogg; Sri Kumar; Helen Passant; Mary Quigley; Liz Sherwin; Alan Stewart; Isabel Syndikus; Jean Tremlett; Yat Tsang; Karen Venables; Duncan Wheatley; Judith M Bliss; John R Yarnold
Journal:  J Clin Oncol       Date:  2020-07-14       Impact factor: 44.544

6.  The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study.

Authors:  Katie Spencer; Christopher M Jones; Rebecca Girdler; Catherine Roe; Michael Sharpe; Sarah Lawton; Louise Miller; Philippa Lewis; Mererid Evans; David Sebag-Montefiore; Tom Roques; Rebecca Smittenaar; Eva Morris
Journal:  Lancet Oncol       Date:  2021-01-22       Impact factor: 41.316

Review 7.  Fraction size in radiation therapy for breast conservation in early breast cancer.

Authors:  Brigid E Hickey; Melissa L James; Margot Lehman; Phil N Hider; Mark Jeffery; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

8.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet       Date:  2008-03-19       Impact factor: 79.321

9.  Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

Authors:  Adrian Murray Brunt; Joanne S Haviland; Duncan A Wheatley; Mark A Sydenham; Abdulla Alhasso; David J Bloomfield; Charlie Chan; Mark Churn; Susan Cleator; Charlotte E Coles; Andrew Goodman; Adrian Harnett; Penelope Hopwood; Anna M Kirby; Cliona C Kirwan; Carolyn Morris; Zohal Nabi; Elinor Sawyer; Navita Somaiah; Liba Stones; Isabel Syndikus; Judith M Bliss; John R Yarnold
Journal:  Lancet       Date:  2020-04-28       Impact factor: 202.731

10.  Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.

Authors:  Joanne S Haviland; Mariella Mannino; Clare Griffin; Nuria Porta; Mark Sydenham; Judith M Bliss; John R Yarnold
Journal:  Radiother Oncol       Date:  2017-11-15       Impact factor: 6.280
View more
  1 in total

1.  Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Authors:  Kelsey L Corrigan; Xiudong Lei; Neelofur Ahmad; Isidora Arzu; Elizabeth Bloom; Stephen G Chun; Chelain Goodman; Karen E Hoffman; Melissa Joyner; Lauren Mayo; Melissa Mitchell; Kevin T Nead; George H Perkins; Valerie Reed; Jay P Reddy; Pamela Schlembach; Simona F Shaitelman; Michael C Stauder; Eric A Strom; Welela Tereffe; Lee Wiederhold; Wendy A Woodward; Benjamin D Smith
Journal:  Adv Radiat Oncol       Date:  2021-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.